Philip Katz, Global | Chambers Profiles

Regional Rankings
Global
Asia-Pacific
Brazil
Canada
Europe
France
Germany
Greater China Region
Latin America
UK
UK Bar
USA
Specialist Rankings
NewLaw
Crisis & Risk Management
FinTech
GC Influencers
High Net Worth
Litigation Support
Spotlight Rankings
USA: Spotlight
Chambers Autumn Release is now live Learn more
Articles
Global Practice Guides
Expert Focus
Diversity, Equity and Inclusion
Legal Articles
Events
Upcoming Events
Browse All Events
Event Sponsorship
About Our Events
Chambers Autumn Release is now live Learn more
Amplify your presence
Profile Platform
Amplify your ranking and be more discoverable
Includes:

Online Profile

Referee Management

Research Analytics

Marketing Toolkit

Plaques
Improve your performance
Insight
Improve your ranking with unique market insight
Includes:

Client and Market Intelligence

Client Intelligence

Rankings Data Hub

Business Intelligence
Showcase your expertise
Global Practice Guides Contributions
Highlight your subject matter expertise
Expert Focus
Provide commentary on key legal matters
In-depth Overviews
Events Sponsorship
Global Practice Guides
View our latest publications
Elevate your talent strategies
Chambers TalentNew
Access a range of ways to gain valuable insights to inform talent strategies
Leading TeamsNew
Heighten your understanding of and identify the key drivers of talent retention and motivation
Chambers Student
Chambers Associate
Chambers Autumn Release is now live Learn more
Submissions
Guide Launch Dates
Methodology
Research Schedule
Research Team
Submissions Process
Chambers Autumn Release is now live Learn more
Help
My Account

Ranked in 1 Practice Areas

3

Band 3

Life Sciences: Regulatory/Compliance

USA

4 Years Ranked

Ranked in Guides

Chambers Review

Provided by Chambers

Global

Life Sciences: Regulatory/Compliance - USA

3

Band 3

Individual Editorial

Philip Katz is a seasoned guide for start-ups and public companies in the biotech and pharmaceuticals industries, frequently assisting clients in the navigation of FDA and other regulatory frameworks. He is well versed in Hatch-Waxman, orphan drug and biosimilars issues and is adept at representing clients in court and before various regulators.

Learn more about this team❖View ranking table

Filter by

Africa-wide

Banking & Finance

Andrew Taylor

Spotlight

David Leggott

Spotlight

Corporate/Commercial: OHADA Specialists

2

Olivier Fille-Lambie

2

Band 2

Project Finance

3

Olivier Fille-Lambie

3

Band 3

Projects & Energy

4

Olivier Fille-Lambie

4

Band 4

5

Arun Velusami

5

Band 5

Australia

Banking & Finance: Corporate Finance

3

Bryan Paisley

3

Band 3

Belgium

Banking & Finance

4

Philip Van Steenwinkel

4

Band 4

Competition: EU

3

Christopher Thomas

3

Band 3

F

Falk Schöning

F

Foreign expert for Germany

Brazil

Capital Markets (International Firms)

U

Jonathan Lewis

U

Up and Coming

Corporate Crime & Investigations (International Firms)

3

Isabel Costa Carvalho

3

Band 3

Corporate/M&A (International Firms)

3

Isabel Costa Carvalho

3

Band 3

Brunei

General Business Law

Rob Palmer

Singapore expertise based abroad

China

Banking & Finance: Hong Kong-based (International Firms)

4

Owen Chan

4

Band 4

Capital Markets: Equity (International Firms)

5

Nelson Tang

5

Band 5

Competition/Antitrust (International Firms)

1

Adrian Emch

1

Band 1

Dispute Resolution: Arbitration (International Firms)

3

James Kwan

3

Band 3

Dispute Resolution: Litigation (International Firms)

3

Chris Dobby

3

Band 3

3

Mark Lin

3

Band 3

20 of 221 results